Antibody Pair for Vascular Endothelial Growth Factor 121 (VEGF121)
- UOM
- FOB US$ 721.00 US$ 1,202.00 US$ 2,164.00 US$ 4,207.00 US$ 7,212.00
- Quantity
Overview
Properties
- Product No.PSB851Hu01
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- ApplicationsELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays.
Research use only - Downloadn/a
- CategoryCytokineSignal transductionTumor immunityInfection immunity
-
Reagent Contents
Recombinant Vascular Endothelial Growth Factor 121 (VEGF121) 50ug Standard Biotin-Linked Polyclonal Antibody to Vascular Endothelial Growth Factor 121 (VEGF121) 100ug Detection Ab Monoclonal Antibody to Vascular Endothelial Growth Factor 121 (VEGF121) 500ug Capture Ab
Sign into your account
Share a new citation as an author
Upload your experimental result
Review

Contact us
Please fill in the blank.
Matching tests
Usage
The concentration of protein/peptide and antibodies used in different immunoassays need to be determined by users according to their experiments.
Storage
Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
Stability
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
Giveaways
Increment services
Citations
- Elevated PLGF contributes to small-cell lung cancer brain metastasisPubMed: 22797069
- VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastomaPubmed:29747600
- A pediatric case of anaplastic astrocytoma with a gliomatosis cerebri; the growth pattern and changes in serum VEGF-121 levels after bevacizumab treatmentPubmed: 33222957
- Associations between VEGF isoforms and impending retinopathy of prematurityPubmed: 32737903
- Activin A triggers angiogenesis via regulation of VEGFA and its overexpression is associated with poor prognosis of oral squamous cell carcinomaPubmed: 32377747